• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与乳腺浸润性癌相关的导管内癌。两种病变的比较及其对导管内癌分类系统的意义。

Intraductal carcinoma associated with invasive carcinoma of the breast. A comparison of the two lesions with implications for intraductal carcinoma classification systems.

作者信息

Goldstein N S, Murphy T

机构信息

Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.

出版信息

Am J Clin Pathol. 1996 Sep;106(3):312-8. doi: 10.1093/ajcp/106.3.312.

DOI:10.1093/ajcp/106.3.312
PMID:8816587
Abstract

Intraductal carcinoma (DCIS) is a useful marker for predicting which women will develop a recurrent breast malignancy. The authors examined 150 consecutive, mammographically detected, T1 invasive carcinomas associated with DCIS to study the DCIS and compare it to its associated invasive carcinoma. Intraductal carcinoma nuclear grades were assigned to each duct on a scale of 1 to 3. The percentage of DCIS ducts that were involved by each grade was quantitated into quartiles for cases with more than one DCIS nuclear grade. The predominant architectural pattern corresponding to each DCIS nuclear grade was recorded. Ninety-two percent of the 150 invasive carcinomas were of ductal type, 4% were tubular, and the remainder were various other subtypes. Nine percent of the DCIS cases were nuclear grade 1. The remaining 91% of cases were almost evenly distributed between mixed DCIS nuclear grades 1 and 2 (19%), pure DCIS nuclear grade 2 (24%), mixed DCIS nuclear grade 2 to 3 (25%), and pure DCIS nuclear grade 3 (22%). Two percent of cases were a mixture of DCIS nuclear grades 1 and 3 or 1, 2, and 3. All pure DCIS nuclear grade 1 or mixed 1 and 2 were associated with well or moderately differentiated invasive carcinomas, whereas the majority (61%) of the pure DCIS nuclear grade 3 cases were associated with poorly differentiated invasive carcinomas. There was no relation between the DCIS architectural pattern and the invasive carcinoma grade. In general, the DCIS nuclear grade correlates with the grade of the invasive carcinoma. Unlike DCIS architecture, nuclear grade heterogeneity within DCIS associated with invasive carcinoma is minimal. DCIS classification systems based on nuclear grade have merit because there is little variation in nuclear grade within a given patient's lesion.

摘要

导管原位癌(DCIS)是预测哪些女性会发生复发性乳腺恶性肿瘤的有用标志物。作者检查了150例连续的、经乳腺X线摄影检测出的与DCIS相关的T1期浸润性癌,以研究DCIS并将其与其相关的浸润性癌进行比较。对每个导管的导管原位癌核分级按1至3级进行评定。对于具有多个DCIS核分级的病例,将每个分级累及的DCIS导管百分比定量为四分位数。记录与每个DCIS核分级相对应的主要结构模式。150例浸润性癌中92%为导管型,4%为小管型,其余为其他各种亚型。9%的DCIS病例为核1级。其余91%的病例几乎均匀分布在混合DCIS核1级和2级(19%)、纯DCIS核2级(24%)、混合DCIS核2级至3级(25%)和纯DCIS核3级(22%)之间。2%的病例为DCIS核1级和3级或1级、2级和3级的混合。所有纯DCIS核1级或混合1级和2级均与高分化或中分化浸润性癌相关,而大多数(61%)纯DCIS核3级病例与低分化浸润性癌相关。DCIS结构模式与浸润性癌分级之间无相关性。一般来说,DCIS核分级与浸润性癌分级相关。与DCIS结构不同,与浸润性癌相关的DCIS内的核分级异质性最小。基于核分级的DCIS分类系统具有优点,因为在给定患者的病变内核分级变化很小。

相似文献

1
Intraductal carcinoma associated with invasive carcinoma of the breast. A comparison of the two lesions with implications for intraductal carcinoma classification systems.与乳腺浸润性癌相关的导管内癌。两种病变的比较及其对导管内癌分类系统的意义。
Am J Clin Pathol. 1996 Sep;106(3):312-8. doi: 10.1093/ajcp/106.3.312.
2
Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.原位导管癌伴大汗腺型突起细胞导致乳腺小扩张导管癌变:一种与小管癌相关的病变。
Am J Clin Pathol. 1997 May;107(5):561-6. doi: 10.1093/ajcp/107.5.561.
3
Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.乳腺导管内癌(原位导管癌)。纯非浸润性肿瘤与包含不同比例浸润性癌的肿瘤的比较。
Cancer. 1994 Dec 1;74(11):2972-8. doi: 10.1002/1097-0142(19941201)74:11<2972::aid-cncr2820741113>3.0.co;2-z.
4
Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的细胞学和结构异质性。
J Clin Pathol. 1997 Jul;50(7):596-9. doi: 10.1136/jcp.50.7.596.
5
Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma--a preliminary report.男性乳腺导管原位癌(DCIS):84例纯DCIS及30例合并浸润性癌的DCIS的形态学研究——初步报告
Cancer. 1998 Nov 15;83(10):2139-49. doi: 10.1002/(sici)1097-0142(19981115)83:10<2139::aid-cncr12>3.0.co;2-f.
6
An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.乳腺导管原位癌的评估及其与相关浸润性成分分级的相关性。
Indian J Pathol Microbiol. 2001 Jul;44(3):297-300.
7
Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.乳腺单纯导管原位癌及导管浸润癌的原位成分。一项初步形态计量学研究。
J Exp Clin Cancer Res. 2003 Jun;22(2):279-88.
8
The impact of large sections on the study of in situ and invasive duct carcinoma of the breast.大片段对乳腺原位癌和浸润性导管癌研究的影响。
Hum Pathol. 2007 Dec;38(12):1736-43. doi: 10.1016/j.humpath.2007.04.007. Epub 2007 Aug 21.
9
Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions.
Pathol Int. 1998 Jul;48(7):518-25. doi: 10.1111/j.1440-1827.1998.tb03943.x.
10
Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.细胞角蛋白标志物、雌激素受体α(ER-α)、孕激素受体(PR)、人表皮生长因子受体2/neu(HER-2/neu)和表皮生长因子受体(EGFR)在乳腺单纯导管原位癌(DCIS)及合并浸润性导管癌(IDC)的DCIS中的表达。
Ann Clin Lab Sci. 2007 Spring;37(2):127-34.

引用本文的文献

1
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis.乳腺导管原位癌微浸润的预后意义:一项荟萃分析。
Breast Cancer Res Treat. 2023 Jan;197(2):245-254. doi: 10.1007/s10549-022-06800-3. Epub 2022 Nov 24.
2
Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast.乳腺导管原位癌(DCIS)累及的相同核级导管之间的异质性。
Cancer Inform. 2010 Sep 7;9:209-16. doi: 10.4137/cin.s5505.
3
Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.
避免异质性肿瘤统计分析中的陷阱。
Biomed Inform Insights. 2009 Jan 1;2:11-18. doi: 10.4137/bii.s2222.
4
Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.乳腺导管原位癌(DCIS)定量核图像特征对复发的影响。
Cancer Inform. 2008;6:99-109. doi: 10.4137/cin.s401. Epub 2008 Mar 1.
5
Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast.同一乳腺的正常导管、导管原位癌及浸润性癌中c-erbB-2和p53的蛋白表达
Sao Paulo Med J. 2006 May 4;124(3):121-4. doi: 10.1590/s1516-31802006000300002.
6
Electron microscopic findings for diagnosis of breast lesions.用于乳腺病变诊断的电子显微镜检查结果
Med Mol Morphol. 2005 Dec;38(4):216-24. doi: 10.1007/s00795-005-0300-9.
7
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast.乳腺单纯导管原位癌治疗后原位复发及浸润性癌的分级
Br J Cancer. 2004 Apr 19;90(8):1538-42. doi: 10.1038/sj.bjc.6601704.
8
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.导管原位癌保乳治疗后原发性肿瘤与其局部复发的组织学类型和标志物表达比较。
Br J Cancer. 2001 Feb;84(4):539-44. doi: 10.1054/bjoc.2000.1618.
9
Minimal breast cancer: evaluation of histology and biological marker expression.微小乳腺癌:组织学及生物标志物表达评估
Br J Cancer. 1999 Jul;80(10):1608-16. doi: 10.1038/sj.bjc.6690570.